Mediation Mendelian Randomization Analysis of the Effect of Immune Cells on Autism Spectrum Disorder Mediated by Inflammatory Factors.

This large genetic study looked at how the immune system might contribute to autism. Researchers found that certain immune cells and inflammatory molecules in the body may increase autism risk. Specifically, they identified changes in immune cell types and inflammatory signals that could affect brain development. While this helps us understand how autism might develop, more research is needed before this knowledge can be used in treatment.

This mediation Mendelian randomization study investigated causal pathways between immune cells, inflammatory factors, and autism spectrum disorder (ASD) risk using genetic data from 18,382 ASD cases and 27,969 controls. The research examined 731 immune phenotypes and 48 cytokines to identify potential causal relationships. Key findings revealed that specific immune cell populations (CD8+ T cells, CCR2+ myeloid dendritic cells, CD45+ immature myeloid-derived suppressor cells) showed causal associations with ASD risk. Additionally, abnormal levels of inflammatory mediators including reduced Artemin and elevated FLT3L and 2B4 were significantly linked to ASD risk.

The study provides evidence that immune dysfunction may contribute to ASD pathophysiology through inflammatory pathways, though functional validation is required before clinical application.

Findings suggest immune system dysfunction may contribute to ASD through inflammatory pathways, potentially informing future therapeutic targets. However, functional validation and replication studies are needed before clinical translation. Results may guide development of immune-based biomarkers for ASD risk assessment.

Study relies on genetic associations rather than direct causal evidence. Functional validation is explicitly required before clinical application. The specific mechanisms linking immune dysfunction to ASD pathophysiology remain unclear despite statistical associations.

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition that impairs communication. Increasing research indicates that maternal immune activation (MIA) is one of the most important environmental factors that increase the risk of autism spectrum disorder (ASD) in offspring. Maternal immune activation produces elevated cytokine levels that cross the placental barrier and disrupt fetal neurodevelopment, increasing ASD risk. However, the specific causal pathways and mediating mechanisms remain unclear, limiting our understanding.

This mediation Mendelian randomization study examined causal pathways linking immune cell traits (exposures) and inflammatory factors (mediators) to ASD risk.The research merged immune data (731 phenotypes + 48 cytokines) and ASD data from a cohort comprising 18,382 cases and 27,969 controls. Various MR approaches were used to reduce potential biases, along with thorough descriptions of statistical procedures and instrumental variable selection. The study's findings propose potential causal relationships among cytokines representing inflammatory factors, immune cells, and ASD through mediation Mendelian randomization. Reverse MR was then employed to investigate the possibility of reverse causality.

CD8+ T cell %leukocyte (OR = 1.099, 95% CI: 1.039-1.163, p = 0.001), CCR2+ CD62L+ myeloid dendritic cells (OR = 0.933, p = 0.029), and CD45+ immature myeloid-derived suppressor cells (OR = 1.056, p = 0.001) showed evidence of causal association with ASD risk.Furthermore, reduced Artemin levels and elevated FLT3L and 2B4 levels were significantly linked to ASD risk, indicating that abnormalities in immunomodulatory factors may play a crucial role in the pathogenesis of ASD. Additionally, ASD occurrence may result in alterations in Natural Killer cell receptor 2B4 levels. This mediation Mendelian randomization study provides evidence that immune dysfunction is associated with ASD pathophysiology through inflammatory mediators, requiring functional validation before clinical application.Cytokines act as mediators in the pathogenesis of ASD, providing a theoretical basis for understanding its immunoinflammatory pathogenesis and offering insight into treatment.